Neurology

The Blueprint: SCN1A Genetics and Diagnosis

At a Glance

Dravet syndrome is typically caused by a spontaneous SCN1A gene mutation that disrupts the brain's ability to stop seizures. Identifying this mutation through genetic testing is crucial to confirm the diagnosis and prevent doctors from prescribing harmful sodium channel-blocking medications.

To understand Dravet syndrome, it helps to think of the brain as a complex electrical circuit. For this circuit to work correctly, it needs a balance of “gas pedals” that send signals and “brakes” that slow them down. In a child with Dravet syndrome, the biological blueprint for those brakes is missing a critical piece ^[1]^[2].

The Biology: Why the Brakes Fail

The vast majority of Dravet syndrome cases are caused by a mutation in the SCN1A gene ^[1]. This gene provides the instructions for making a tiny protein gate called the NaV1.1 sodium channel ^[1].

Haploinsufficiency: In most children with Dravet, one of the two copies of the SCN1A gene is broken or missing. This state is called haploinsufficiency—meaning “half is not enough” ^[1]^[3].
The GABAergic Interneurons: These sodium channels are primarily found on the brain’s “brake” cells, known as GABAergic interneurons ^[2]. When these interneurons don’t have enough working channels, they can’t fire properly.
The Result: Without the “brakes” to slow things down, the “gas pedal” cells (excitatory neurons) run wild. This leads to the electrical storm we recognize as a seizure ^[2]^[4].

Dravet Syndrome vs. Simple Febrile Seizures

It is very common for a child’s first Dravet seizure to be mistaken for a “simple febrile seizure,” which many healthy children experience. However, there are key differences that doctors look for:

Feature	Simple Febrile Seizure	Dravet Syndrome Seizure
Age of Onset	Typically peaks in toddlerhood (12-18 months)	Often begins earlier (5-8 months) ^[5]
Duration	Usually short (under 5 minutes)	Often prolonged (over 15–30 minutes) ^[6]
Body Movement	Affects both sides of the body	Often affects only one side (hemiclonic) ^[6]
Frequency	Rare; usually one per illness	Can happen multiple times in 24 hours ^[5]
Triggers	Only triggered by high fever	Triggered by low fever, warm baths, or exercise ^[5]

Decoding the Genetic Testing Report

If your child has had genetic testing, the report can be intimidating. Here are the specific terms you should look for and what they mean for your child’s care:

Pathogenic or Likely Pathogenic: This means the lab is 90% to 100% certain that this specific mutation is the cause of the condition ^[7]^[8]. This result confirms the diagnosis and is a “green light” for doctors to use Dravet-specific treatments.
Variant of Uncertain Significance (VUS): This is a “maybe.” It means the lab found a change in the SCN1A gene, but they don’t have enough data yet to know if it’s a harmless natural variation or the cause of the seizures ^[7]. If your child has a VUS but their symptoms match Dravet perfectly, doctors often treat it as Dravet anyway.
De Novo: This term means the mutation happened spontaneously in the child and was not inherited from either parent ^[9]. Most SCN1A mutations in Dravet syndrome are de novo.

Confirming an SCN1A mutation is a critical milestone. It allows your medical team to immediately stop using medications that block sodium channels—drugs that might work for other kids but can be dangerous for yours ^[10]^[8]. This genetic “map” helps your doctor choose the safest path forward.

Common questions in this guide

What causes Dravet syndrome?

Most cases of Dravet syndrome are caused by a mutation in the SCN1A gene. This gene provides instructions for making a protein that acts like a brake in the brain. Without enough of these working proteins, electrical signals can run out of control and cause seizures.

How is a Dravet syndrome seizure different from a simple febrile seizure?

Simple febrile seizures are usually brief and triggered only by high fevers. In contrast, Dravet syndrome seizures often last longer than 15 minutes, may affect only one side of the body, and can be triggered by low-grade fevers, warm baths, or even exercise.

What does a Variant of Uncertain Significance (VUS) mean on my child's genetic report?

A VUS means the lab found a change in the SCN1A gene but does not yet have enough data to know if it causes seizures or is a harmless natural variation. If your child's symptoms closely match Dravet syndrome, doctors will often treat the condition as Dravet while gathering more information.

What does "De Novo" mean on a genetic test result?

The term De Novo means that the genetic mutation occurred spontaneously in your child and was not inherited from either parent. This is the most common way SCN1A mutations occur in children with Dravet syndrome.

Why is confirming an SCN1A mutation so important for my child's treatment?

Confirming an SCN1A mutation gives your medical team the information they need to choose the safest treatments. Specifically, it alerts doctors to immediately stop or avoid using sodium channel-blocking medications, which might help other types of epilepsy but can be dangerous for a child with Dravet syndrome.

Curated prompts to bring to your next appointment.

1.Is the specific SCN1A mutation my child has a 'truncating' mutation or a 'missense' variant, and does that change the prognosis?
2.Since my child has an SCN1A mutation, are there specific 'sodium channel blocker' medications we must avoid from now on?
3.The report lists a 'Variant of Uncertain Significance' (VUS)—how do we determine if this is actually the cause of the seizures?
4.Does our child's diagnosis fall under the broader 'GEFS+' spectrum, or is it classic Dravet syndrome?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (10)

1
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
Kaplan JS, Stella N, Catterall WA, Westenbroek RE
Proceedings of the National Academy of Sciences of the United States of America 2017; (114(42)):11229-11234 doi:10.1073/pnas.1711351114.
PMID: 28973916
2
A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
Sun Y, Paşca SP, Portmann T, et al.
eLife 2016; (5()).
PMID: 27458797
3
Investigational new drugs for the treatment of Dravet syndrome: an update.
Janković SM, Janković SV, Vojinović R, Lukić S
Expert opinion on investigational drugs 2023; (32(4)):325-331 doi:10.1080/13543784.2023.2193680.
PMID: 36932738
4
Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.
Dyment DA, Schock SC, Deloughery K, et al.
Genetics 2020; (215(4)):1055-1066 doi:10.1534/genetics.120.303399.
PMID: 32554600
5
Dravet Syndrome: An Overview.
Anwar A, Saleem S, Patel UK, et al.
Cureus 2019; (11(6)):e5006 doi:10.7759/cureus.5006.
PMID: 31497436
6
Incidence of Dravet Syndrome in a US Population.
Wu YW, Sullivan J, McDaniel SS, et al.
Pediatrics 2015; (136(5)):e1310-5 doi:10.1542/peds.2015-1807.
PMID: 26438699
7
Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.
Shi XY, Tomonoh Y, Wang WZ, et al.
Brain & development 2016; (38(1)):40-6.
PMID: 26183863
8
SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis.
Ding J, Li X, Tian H, et al.
Frontiers in neurology 2021; (12()):743726 doi:10.3389/fneur.2021.743726.
PMID: 35002916
9
[Analysis of parental origin of de novo SCN1A mutations in Dravet syndrome].
Sun H, Zhang Y, Xu X, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2015; (32(4)):457-61 doi:10.3760/cma.j.issn.1003-9406.2015.04.001.
PMID: 26252084
10
Dravet Syndrome: Diagnosis and Long-Term Course.
Connolly MB
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2016; (43 Suppl 3()):S3-8 doi:10.1017/cjn.2016.243.
PMID: 27264139

This page provides educational information about SCN1A genetics and Dravet syndrome diagnosis. Always consult a pediatric neurologist or genetic counselor to interpret your child's specific genetic testing results and guide their treatment.

Get notified when new evidence is published on Dravet syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents